WKN DE: A41BR2 / ISIN: US1711262048

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Pelthos Therapeutics Times and Sales (AMEX)

Zeit	Kurs	Umsatz (Stk)
17:26:26	27,930	1
17:25:37	27,850	35
17:22:28	27,840	1
17:22:18	27,840	1
17:22:06	27,840	1
17:09:57	27,960	100
17:07:43	28,050	100
17:06:55	28,080	59
17:05:15	28,000	35
17:04:40	27,870	100
17:03:21	28,100	1
17:01:53	28,100	11
17:01:53	28,100	11
17:01:53	28,100	2
17:01:53	28,100	34
17:01:53	28,050	50
17:01:53	28,050	3
17:01:10	28,060	5
17:01:10	28,060	5
17:01:10	28,050	5
17:01:10	28,050	10
17:00:47	28,000	50
17:00:47	28,000	50
16:59:55	28,060	32
16:59:47	28,060	21
16:56:33	28,100	50
16:56:30	28,150	50
16:56:25	28,200	50
16:56:25	28,200	50
16:56:12	28,200	50
16:55:48	28,250	1
16:55:48	28,250	99
16:55:48	28,220	99
16:55:48	28,220	1
16:55:24	28,110	50

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Nachrichten zu Pelthos Therapeutics Inc

13.05.26

Ausblick: Pelthos Therapeutics stellt Zahlen zum jüngsten Quartal vor

Analysen zu Pelthos Therapeutics Inc

Weitere Meldungen

16:55		Why US train travel lags behind Asia and Europe
16:55		Why Volkswagen's huge workforce became a costly burden
16:55		Conflict, climate change, cash-strapped: Why poverty persists
16:55		Brain tumors: New vaccine offers patients hope for more time
16:55		Assassin's Creed: Why pop culture is hooked on pirates
16:55		What's behind Germany's World Cup woes?
16:55		Why the World Cup can be good for your mental health
16:55		Ukraine's Bidnyi 'outraged' by Russia's Olympic return
16:55		Heat is especially hard on people taking antidepressants
16:55		World Cup: Balogun red and expansion keep FIFA in spotlight
16:45		$1000 Invested In Vanguard Morningstar Mega Cap Growth ETF 10 Years Ago Would Be Worth This Much Today
16:44		Here’s Why the US Is Helping Prop Up the Japanese Yen
16:44		Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue
16:44		Reddit Stock Gains Monday: What's Driving the Post-Earnings Rebound?
16:44		Uber Reports Earnings on Aug. 5, Followed by Lyft on Aug. 6. Here's the Better Buy Now.
16:40		Why Oracle Stock Is Gaining
16:37		What Is Going on With Oracle Stock on Monday?
16:32		What's Wrong With Micron Technology Stock?
16:30		If You Invested $1000 In Teradyne Stock 15 Years Ago, You Would Have This Much Today
16:30		Greg Abel Closed Berkshire Hathaway's Taylor Morrison Deal on July 24. Here's What Berkshire Owns Now.
16:27		Visa And Samsung Expand Stablecoin Push As CLARITY Act Faces Final Senate Test
16:27		From Reverse Splits to Goodwill Surge - Fugazi Research Claims T3 Defense Is “Uninvestable”
16:24		This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
16:23		These Analysts Revise Their Forecasts On T. Rowe Price Following Q2 Earnings
16:22		SpaceX’s Stock Lockup Is Expiring. Prepare for a Bumpy Ride.
16:18		These Analysts Boost Their Forecasts On Gates Industrial After Better-Than-Expected Q2 Earnings
16:15		$100 Invested In Fidelity MSCI Information Technology Index ETF 5 Years Ago Would Be Worth This Much Today
16:15		PayPal Shares Pause as Turnaround Momentum Collides With Overbought RSI
16:14		Marvell Technology Stock Is Falling Monday: What's Going On?
16:13		American manufacturers grow at fastest clip in 4 years due to AI boom — but all is not well
16:11		Amazon enters US$3 trillion club as Wall Street opens higher on Middle East deal hopes
16:11		Apple launches legal challenge to UK attempt to access encrypted user data
16:07		3 Reasons to Buy Nvidia Stock in August
16:05		Forget Rockets. This Is The Real Reason Wall Street Can't Stop Buying SpaceX.
16:00		CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday
16:00		Here's How Much $1000 Invested In Costco Wholesale 15 Years Ago Would Be Worth Today
15:58		Palo Alto Networks Stock Is Gaining Monday: What's Going On?
15:56		QUICK SPARK: Warren Buffett's Berkshire Hathaway Just Flashed a Golden Cross
15:54		Marriott’s Q3 profit forecast falls short of estimates as Middle East revenue drops
15:50		Strategy Sold 1,638 BTC for $105 Million: Will MSTR Now Plunge Below $90?
15:50		Time for Andy Burnham to smile on UK science
15:45		Palantir Earnings Prediction Market Preview: What Will Alex Karp Say?
15:44		AMD Options Price A 9% Swing On Earnings: What Does History Say?
15:43		Dow Surges 600 Points; Tyson Foods Shares Fall After Q3 Results
15:41		Bloom Energy Stock Dips Monday: What's Driving the Post-Earnings Reset?
15:40		WeRide Teams Up With GreenMobility To Launch Denmark Robotaxis
15:34		SpaceX Could Burn Through Billions More as Elon Musk Ramps Up AI Spending With Tesla: Analyst Says Free Cash Flow is 'Just Not Part of the Story'
15:26		Taiwan Semiconductor Just Reclaimed a $2 Trillion Market Cap. It Still Trades at About 20 Times Forward Earnings.
15:23		Intel Stock Is Falling Monday: What's Going On?
15:21		Struggling to make sense of AstraZeneca-BMS

Zurück | 1 | 2 | 3 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: IRC Globe Civil Projects Masterworks 255 LLC Regisered a City View Green Holdings Info-Tech Systems

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	03.08.2026 19:36
Kaufwert:	EUR
	Hinzufügen Speichern

Pelthos Therapeutics Aktie

WKN DE: A41BR2 / ISIN: US1711262048

Pelthos Therapeutics Times and Sales (AMEX)

Nachrichten zu Pelthos Therapeutics Inc

Analysen zu Pelthos Therapeutics Inc

Weitere Meldungen